# Aspirin Discontinuation in High-Risk Pregnant Women of Preeclampsia

> **NCT06111079** · PHASE3 · RECRUITING · sponsor: **FANG HE** · enrollment: 1800 (estimated)

## Conditions studied

- Preeclampsia
- Perinatal Haemorrhage

## Interventions

- **DRUG:** aspirin discontinuation
- **DRUG:** aspirin continuation

## Key facts

- **NCT ID:** NCT06111079
- **Lead sponsor:** FANG HE
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-11-01
- **Primary completion:** 2024-12-30
- **Final completion:** 2024-12-31
- **Target enrollment:** 1800 (ESTIMATED)
- **Last updated:** 2024-07-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06111079

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06111079, "Aspirin Discontinuation in High-Risk Pregnant Women of Preeclampsia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06111079. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*